Targeted delivery using immunoliposomes with a lipid-modified antibody-binding protein

Area of Science:

• Biotechnology
• Molecular Biology
• Cell Biology

Background:

• Streptococcal protein G is a well-known antibody-binding protein.
• Liposomes are versatile drug delivery vehicles.
• Targeted delivery of molecules into cells remains a challenge.

Purpose of the Study:

• To develop a novel method for creating targeted immunoliposomes.
• To utilize a modified streptococcal protein G for liposome surface functionalization.
• To demonstrate the efficacy of these immunoliposomes for intracellular delivery of molecular tracers.

Main Methods:

• Site-directed genetic engineering to create a lipid-modified streptococcal protein G (lipoprotein).
• Incorporation of the lipoprotein into liposome surfaces via simple mixing.
• Preparation of immunoliposomes by binding anti-IgG antibodies to the lipoprotein-functionalized liposomes.
• Encapsulation of small fluorophores or fluorescently labeled proteins into the immunoliposomes.

Main Results:

• Successfully created lipid-anchored streptococcal protein G lipoproteins.
• Demonstrated efficient incorporation of lipoproteins onto liposome surfaces.
• Prepared functional immunoliposomes capable of binding to antibody-marked cells.
• Showcased successful delivery of encapsulated molecular tracers into target cells.

Conclusions:

• The developed immunoliposomes provide an effective platform for targeted molecular delivery into specific cells.
• Lipid-anchored streptococcal protein G is a valuable tool for surface functionalization of liposomes.
• This approach holds potential for various applications in cell biology and therapeutics.